Blood Collection Market by Product (Tubes (Plasma (EDTA, Heparin, Glucose), Serum), Blood Bags, Monitors, Needles), Method (Manual, Automated), Application (Diagnostic, Therapeutic), End User (Hospitals & ASCs, Blood Banks, Labs) - Global Forecast to 2025
[267 Pages Report] The global blood collection devices market is projected to reach USD 6.4 billion by 2025 from USD 4.8 billion in 2020, at a CAGR of 6.0% between 2020 and 2025. The major factors driving the growth of this market include the increasing incidence of infectious diseases, the rising number of accidents & trauma cases, the emergence of liquid biopsy tests, and a demand for blood donations and blood components.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 impact on the global BLOOD COLLECTION DEVICES market
The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the blood collection devices market.
Both hospital and independent laboratories are generally reviewing each test to decide whether to recommend consultations with laboratory hematologists for tests with a higher risk profile or not offer tests that could not be performed safely. This affected the market negatively in the first few months of the pandemic, reducing the use of blood collection devices. However, increasing caution and the rising testing volumes, along with the need for regular health and body checkups will ensure market growth in a later phase.
Results now take an average of four to six days for the general population, much longer than the two to three days required before. This is because tests for hospital patients and symptomatic healthcare workers are prioritized and take one day on average, which has resulted in a delayed cycle. While it has affected market growth to some extent, the situation is expected to change for the better.
BLOOD COLLECTION DEVICES Market Dynamics
Driver: Increasing chronic & lifestyle diseases
The burden of chronic diseases is rapidly increasing worldwide. Almost half of the total chronic disease deaths are attributable to cardiovascular disease (CVD). In the US alone, as per the American Heart Association, the prevalence of CVD is projected to increase from 36.9% in 2010 to 38.7% by 2020 and 40.5% by 2030. Obesity and diabetes are also showing worrying trends, not only because they already affect a large proportion of the population but also because they have started to appear earlier in life. The prevalence of lifestyle diseases is also growing across the globe, and particularly in emerging countries.
This scenario has ensured greater adherence to health checkups and the growing importance of markers to find disease conditions mainly via blood collection. Health checkups are gaining popularity both at a personal level as well as performed at a corporate level for employee well-being. This will be favorable for the market growth and a significant contributor to the blood collection devices market, as blood tests are a primary mode of diagnosing these diseases.
Restraint : High cost of automated blood collection devices
For blood banks, capital investments in automated blood collection using apheresis devices are very high in comparison to that of whole-blood collection. The average price for devices ranges between USD 45,000 and USD 55,000. Hence, smaller blood banks and hospitals do not opt for this type of blood collection. The cost of therapeutic apheresis is also very high, as it includes the additional cost of disposables—between USD 1,500 and USD 3,000 per patient. Owing to their high costs, the adoption of these automated blood collection products is very low as compared to manual blood collection products in countries such as China and India. This is limiting the overall growth of the blood collection devices market.
The cost of providing apheresis therapy is a matter of almost universal concern. Estimates of costs of individual apheresis treatments are very much available but vary widely. For instance, in the US, the cost of an apheresis procedure is approximately USD 2,500 per treatment. An investment of USD 19,000 to USD 32,000 for a blood cell separator is the initial cost for setting up the machine, and disposable sets produced by manufacturers will vary between USD 40 and USD 90 per treatment. Replacement fluids (at an average volume of 2.8 liters), such as albumin or fresh frozen plasma, make up the remainder of the costs, running USD 125 to USD 600 per treatment
Challenge: Complexities of storage and shipping
Storing and shipping whole blood samples poses significant challenges and costs. Once collected, whole blood must be used immediately or stored and maintained under strict temperature and environmental conditions for analysis or other applications. The characteristics of blood samples begin to change within hours of collection if not refrigerated or frozen. Maintaining their stability is essential since blood components begin to degrade immediately; extended exposure to ambient temperatures can dramatically affect the outcome of any analysis on such samples. Therefore, medical organizations around the world have created guidelines for their storage, packaging, and shipping.
For example, the US FDA recommends that whole blood samples held in specialized containers should only be kept refrigerated for 42 days. However, it is recognized that some changes in the samples may occur during that time. Another governing body, the National Institute of Health and Welfare in Finland, determined that whole blood samples refrigerated at 4° C (or about 39° F) should only be held for up to seven days before discarding.
Opportunity: Technological advancements in blood collection procedures and products
Collecting blood samples from patients with difficult venous access (DVA) is challenging or sometimes impossible. In DVA patients, traditionally used blood collection products are often unable to collect adequate samples, which can also lead to repeated attempts to collect blood. This increases the risk of anemia in patients and the risk of transmission of blood-borne pathogens to nurses and phlebotomists.
To overcome this issue, innovative hematology-tube designs have been introduced to support capillary-blood collection for reducing the risks of collection and processing errors in DVA patients. Besides this, a vein illumination and visualization technique—vein finder, a recent addition to safe blood collection procedures—is used to assist healthcare professionals in finding a good vein for venipuncture. The device illuminates the veins beneath the skin using ultrasound or infrared technology and facilitates easy vein access, thus reducing the need for repeated venipuncture.
There is a growing trend toward innovations in blood collection. Two firms won US FDA 510(k) clearances for blood collection devices recently—a push-button device from Seventh Sense called TAP, and a needle-free device from Velano Vascular called Pivo. Meanwhile, other firms, such as Neoteryx, are pursuing microsampling of blood but focusing on dried blood spots.
“Hospitals, ASCs, & Nursing homesaccounted for the largest market share in 2019”
In 2019, the hospitals, ASCs, & nursing homes segment accounted for the largest share of the blood collection devices market. Growth in this market segment can be attributed to the increasing incidence of infectious diseases and the rise in the number of trauma cases, as well as C-sections and organ transplants, have ensured the demand for blood collection equipment and devices in hospital facilities.
Clinical laboratories dominated the blood collection devices market in 2019
On the basis of end user, the blood collection devices market is segmented into hospitals, ASCs, & nursing homes, blood banks, diagnostic & pathology laboratories, and other end users. In 2019, the hospitals, ASCs, & nursing homes segment accounted for the largest share of the blood collection devices market.
North America accounted for the largest share of the global blood collection devicesmarket in 2019.
North America (comprising the US and Canada) accounted for the largest share of the global blood collection devices market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the region are stimulating the growth of the blood collection devices market in North America.
To know about the assumptions considered for the study, download the pdf brochure
Some of the key players include Becton, Dickinson and Company (US), , Haematonics (US), Terumo BCT (Japan), Fresenius Kabi AG (Germany), Grifols (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. (Germany), Macopharma (France), Smiths Medical (US), Kawasumi Laboratories (Japan), Retractable Technologies (US), LiuyangSanli Medical Technology Development (China), F.L. Medical S.R.L (Italy), AB Medical (South Korea), APTCA SPA (Italy), MicsafeMedical Group Limited (China), DiseraTibbiMalzemeLojistik Sanayi VeTicaret A.ª (Turkey), Ajosha Bio Teknik Pvt. Ltd. (India), Preq Systems (India), CML Biotech (India), LmbTechnologie GmbH (Germany), Mitra Industries Private Limited (India) and Neomedic Limited (UK).
|
Report Metric |
Details |
|
Market Size Available for Years |
2017–2025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2020–2025 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Method, Product, Application, End User, and Region |
|
Geographies Covered |
North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa |
|
Companies Covered |
Becton, Dickinson and Company (US), , Haematonics (US), Terumo BCT (Japan), Fresenius Kabi AG (Germany), Grifols (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. (Germany), Macopharma (France), Smiths Medical (US), Kawasumi Laboratories (Japan), Retractable Technologies (US), LiuyangSanli Medical Technology Development (China), F.L. Medical S.R.L (Italy), AB Medical (South Korea), APTCA SPA (Italy), Micsafe Medical Group Limited (China), DiseraTibbiMalzemeLojistik Sanayi VeTicaret A.ª (Turkey), Ajosha Bio Teknik Pvt. Ltd. (India), Preq Systems (India), CML Biotech (India), LmbTechnologie GmbH (Germany), Mitra Industries Private Limited (India) and Neomedic Limited (UK) |
This research report categorizes the blood collection devices market into the following segments:
Blood collection devices Market, by Product
- Blood Collection tubes
- Plasma/whole-blood tubes
- EDTA Tubes
- Heparin Tubes
- Coagulation Tubes
- Glucose Tubes
- ESR Tubes
- Serum Tubes
- System Type
- Vacuum Tubes
- Non-vacuum Tubes
- Needles & Syringes
- Blood Bags
- Blood Collection Systems/Monitors
- Lancets
Blood collection devices Market, by Application
- Diagnostics
- Therapeutics
Blood collection devices Market, by Method
- Manual Blood Collection
- Automated Blood Collection
Blood collection devices Market, by End User
- Hospitals, Ambulatory Surgical Centers, & Nursing Homes
- Diagnostic & Pathology Laboratories
- Blood Banks
- Other End Users
Blood collection devices Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments:
- In 2020, F.L. Medical SRL Launched VACUMED Tech blood collection sets with pre-attached holders
- In 2020, BD had an agreement with Babson Diagnostics (US) To enable small-volume blood collection for diagnostic testing in retail settings
- In 2020, Quest Diagnostics acquired Outreach Lab Businesses of Community Health Network and Ascension St. Vincent (US)
Frequently Asked Questions (FAQ):
What is theprojected market of the global blood collection devices market in 2025?
The projected market of the global blood collection devices market is expected to be 6.4bilion in 2025.
Who are the leading players in the blood collection devices market?
Some of the leading players in the blood collection devices market include Becton, Dickinson and Company (US), ,Haematonics (US), Terumo BCT (Japan), Fresenius Kabi AG (Germany), Grifols (Spain) and Macopharma (France)
Who are the major end-users of the blood collection devices market?
The end user of the blood collection devices market includeshospitals, ASCs, & nursing homes, blood banks, diagnostic & pathology laboratories, and other end users.HospitalsASCs, & nursing homes are the largest end-users in the blood collection devices market.
What are the major methods in the blood collection devicesmarket?
By method, the global blood collection devices market is segmented into manual and automated blood collection. The manual blood collection segment is expected to dominate the global market. However, the automated blood collection segment is projected to register a higher CAGR during the forecast period.
What are the major applications in the blood collection devices market?
By application, the global blood collection devices market is segmented into diagnostics and therapeutics. The diagnostics segment is expected to dominate the blood collection devices market during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 40)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
FIGURE 1 BLOOD COLLECTION DEVICES MARKET SEGMENTATION
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 44)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 KEY DATA FROM SECONDARY RESEARCH
2.1.1.1 Secondary sources
2.1.2 KEY DATA FROM PRIMARY RESEARCH
2.1.2.1 Breakdown of primaries
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 4 BLOOD COLLECTION DEVICES MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 51)
3.1 INTRODUCTION
FIGURE 6 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020 VS. 2025 (USD MILLION)
FIGURE 8 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 55)
4.1 BLOOD COLLECTION DEVICES MARKET OVERVIEW
FIGURE 11 INCREASING DISEASE INCIDENCE AND DEMAND FOR BLOOD COMPONENTS TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD & COUNTRY (2020)
FIGURE 12 MANUAL BLOOD COLLECTION TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET 56
4.3 BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 13 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE BLOOD COLLECTION DEVICES MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 57)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 14 BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising disease incidence
FIGURE 15 INCREASE IN HEPATITIS PREVALENCE, 2010–2017
5.2.1.2 Rising number of accidents & trauma cases
5.2.1.3 Emergence of liquid biopsy tests
5.2.1.4 Demand for blood donations and blood components
5.2.2 RESTRAINTS
5.2.2.1 High costs of automated blood collection devices
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for apheresis
5.2.3.2 Technological advancements in blood collection procedures and products
5.2.3.3 Advancements in blood collection—microsampling and dried blood sampling
5.2.4 CHALLENGES
5.2.4.1 Complexities of storage and shipping
5.2.4.2 Lack of skilled professionals
6 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT (Page No. - 63)
6.1 INTRODUCTION
TABLE 1 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 2 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
6.2 BLOOD COLLECTION TUBES
6.2.1 IMPACT OF COVID-19 ON THE BLOOD COLLECTION TUBES MARKET
6.2.2 BLOOD COLLECTION TUBES MARKET, BY TYPE
TABLE 3 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 4 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 5 BLOOD COLLECTION TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 6 BLOOD COLLECTION TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.1 Plasma/whole-blood tubes
TABLE 7 PLASMA/WHOLE-BLOOD TUBES AVAILABLE IN THE MARKET
TABLE 8 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 9 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 10 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 11 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.1.1 EDTA tubes
6.2.2.1.1.1 EDTA tubes hold the largest share of the plasma/whole-blood collection tubes segment
TABLE 12 EDTA TUBES AVAILABLE IN THE MARKET
TABLE 13 EDTA TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 14 EDTA TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.1.2 Heparin tubes
6.2.2.1.2.1 Heparin tubes eliminate the need to wait for clots to form
TABLE 15 HEPARIN TUBES AVAILABLE IN THE MARKET
TABLE 16 HEPARIN TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 17 HEPARIN TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.1.3 Coagulation tubes
6.2.2.1.3.1 Coagulation studies show high demand for specific tubes
TABLE 18 COAGULATION TUBES AVAILABLE IN THE MARKET
TABLE 19 COAGULATION TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 20 COAGULATION TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.1.4 Glucose tubes
6.2.2.1.4.1 Increasing incidence of diabetes drives the growth of the glucose tubes market
TABLE 21 GLUCOSE TUBES AVAILABLE IN THE MARKET
TABLE 22 GLUCOSE TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 23 GLUCOSE TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.1.5 ESR tubes
6.2.2.1.5.1 The increasing prevalence of prominent diseases supports market growth
TABLE 24 ESR TUBES AVAILABLE IN THE MARKET
TABLE 25 ESR TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 26 ESR TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.2 Serum tubes
6.2.2.2.1 Accuracy and stability are important advantages of using serum tubes
TABLE 27 SERUM TUBES AVAILABLE IN THE MARKET
TABLE 28 SERUM TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 29 SERUM TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.3 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE
6.2.3.1 Impact of COVID-19 on the blood collection tubes market, by system type
TABLE 30 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2019 (USD MILLION)
TABLE 31 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
6.2.3.2 Vacuum tubes
6.2.3.2.1 Advantages of vacuum tubes account for their larger market share
TABLE 32 VACUUM TUBES AVAILABLE IN THE MARKET
TABLE 33 VACUUM TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 34 VACUUM TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.3.3 Non-vacuum tubes
6.2.3.3.1 Cost constraints drive consumer preference toward non-vacuum tubes
TABLE 35 NON-VACUUM TUBES AVAILABLE IN THE MARKET
TABLE 36 NON-VACUUM TUBES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 37 NON-VACUUM TUBES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3 NEEDLES & SYRINGES
6.3.1 INCREASING NUMBER OF BLOOD COLLECTION PROCEDURES IS THE KEY DRIVER OF MARKET GROWTH
TABLE 38 NEEDLES & SYRINGES AVAILABLE IN THE MARKET
TABLE 39 BLOOD COLLECTION NEEDLES & SYRINGES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 40 BLOOD COLLECTION NEEDLES & SYRINGES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.4 BLOOD BAGS
6.4.1 INCREASE IN BLOOD DONATIONS SUSTAINS PURCHASE AND USE OF BLOOD BAGS
TABLE 41 BLOOD BAGS AVAILABLE IN THE MARKET
6.4.2 IMPACT OF COVID-19 ON THE BLOOD BAGS MARKET
6.4.2.1 Standard blood bags
6.4.2.2 Inline systems
6.4.2.3 Filters
TABLE 42 BLOOD BAGS MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 43 BLOOD BAGS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 44 BLOOD COLLECTION BAGS MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 45 BLOOD COLLECTION BAGS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.5 BLOOD COLLECTION SYSTEMS/MONITORS
6.5.1 RISING PREVALENCE OF BLOOD DISORDERS AND DEMAND FOR BLOOD ENSURE USE OF COLLECTION SYSTEMS
TABLE 46 BLOOD COLLECTION SYSTEMS/MONITORS AVAILABLE IN THE MARKET
6.5.2 IMPACT OF COVID-19 ON BLOOD COLLECTION SYSTEMS/MONITORS MARKET
TABLE 47 BLOOD COLLECTION SYSTEMS/MONITORS MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 48 BLOOD COLLECTION SYSTEMS/MONITORS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.6 LANCETS
6.6.1 GOVERNMENT SUPPORT FOR LANCET USE HAS SUPPORTED THEIR ADOPTION
TABLE 49 LANCETS AVAILABLE IN THE MARKET
TABLE 50 BLOOD COLLECTION LANCETS MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 51 BLOOD COLLECTION LANCETS MARKET, BY REGION, 2020–2025 (USD MILLION)
7 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION (Page No. - 91)
7.1 INTRODUCTION
TABLE 52 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 53 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
7.2 DIAGNOSTICS
7.2.1 RISING DISEASE INCIDENCE AND ADOPTION OF POC TESTING WILL DRIVE MARKET GROWTH
7.2.2 IMPACT OF COVID-19 ON THE DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET
TABLE 54 DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 55 DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
7.3 THERAPEUTICS
7.3.1 NORTH AMERICA TO DOMINATE THE MARKET FOR THERAPEUTIC BLOOD COLLECTION
7.3.2 IMPACT OF COVID-19 ON THE THERAPEUTIC BLOOD COLLECTION DEVICES MARKET
TABLE 56 THERAPEUTIC BLOOD COLLECTION DEVICES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 57 THERAPEUTIC BLOOD COLLECTION DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
8 BLOOD COLLECTION DEVICES MARKET, BY METHOD (Page No. - 97)
8.1 INTRODUCTION
TABLE 58 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 59 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
8.2 MANUAL BLOOD COLLECTION
8.2.1 MANUAL BLOOD COLLECTION HOLDS LARGEST MARKET SHARE
8.2.2 IMPACT OF COVID-19 ON THE MANUAL BLOOD COLLECTION DEVICES MARKET
TABLE 60 MANUAL BLOOD COLLECTION DEVICES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 61 MANUAL BLOOD COLLECTION DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
8.3 AUTOMATED BLOOD COLLECTION
8.3.1 HIGHER SAFETY AND EFFICIENCY DRIVE DEMAND FOR AUTOMATED COLLECTION
8.3.2 MARKET TRENDS
8.3.3 IMPACT OF COVID-19 ON THE AUTOMATED BLOOD COLLECTION DEVICES MARKET
TABLE 62 AUTOMATED BLOOD COLLECTION DEVICES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 63 AUTOMATED BLOOD COLLECTION DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
9 BLOOD COLLECTION DEVICES MARKET, BY END USER (Page No. - 102)
9.1 INTRODUCTION
TABLE 64 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 65 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
9.2 HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES
9.2.1 INCREASING DISEASE & TRAUMA INCIDENCE DRIVE MARKET GROWTH
TABLE 66 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES, BY REGION, 2017–2019 (USD MILLION)
TABLE 67 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES, BY REGION, 2020–2025 (USD MILLION)
9.3 DIAGNOSTIC & PATHOLOGY LABORATORIES
9.3.1 MARKET GROWTH IS ATTRIBUTED TO RISING DISEASE INCIDENCE AND INCREASE IN TESTING VOLUMES
TABLE 68 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2017–2019 (USD MILLION)
TABLE 69 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2020–2025 (USD MILLION)
9.4 BLOOD BANKS
9.4.1 RISE IN BLOOD DONATION VOLUMES IS A DIRECT DRIVER OF THE MARKET FOR BLOOD BANKS
TABLE 70 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2017–2019 (USD MILLION)
TABLE 71 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2020–2025 (USD MILLION)
9.5 OTHER END USERS
TABLE 72 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2017–2019 (USD MILLION)
TABLE 73 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020–2025 (USD MILLION)
10 BLOOD COLLECTION DEVICES MARKET, BY REGION (Page No. - 108)
10.1 INTRODUCTION
TABLE 74 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 75 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 16 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET SNAPSHOT
TABLE 76 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
TABLE 77 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 78 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 79 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 80 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 81 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 83 NORTH AMERICA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 84 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2019 (USD MILLION)
TABLE 85 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 86 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 87 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 88 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 89 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 91 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.2.1 US
10.2.1.1 US is the largest market for blood collection devices in North America and a major market globally
10.2.1.2 Impact of COVID-19 on the market in the US
TABLE 92 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 93 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 94 US: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 95 US: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 96 US: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 97 US: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 98 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 99 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 100 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 101 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 102 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 103 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 104 US: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 105 US: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising surgical volumes and burden of cancer drive the market in Canada
10.2.2.2 Impact of COVID-19 on the market in Canada
TABLE 106 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 107 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 108 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 109 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 110 CANADA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 111 CANADA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 112 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 113 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 114 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 115 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 116 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 117 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 118 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 119 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3 EUROPE
TABLE 120 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
TABLE 121 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 122 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 123 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 124 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 125 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 126 EUROPE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 127 EUROPE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 128 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 129 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 130 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 131 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 132 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 133 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 134 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 135 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany holds the largest share of the market in Europe
10.3.1.2 Impact of COVID-19 on the market in Germany
TABLE 136 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 137 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 138 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 139 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 140 GERMANY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 141 GERMANY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 142 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 143 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 144 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 145 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 146 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 147 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 148 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 149 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Favorable initiatives, development of diagnostic tests showcase growth trajectory in France
10.3.2.2 Impact of COVID-19 on the market in France
TABLE 150 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 151 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 152 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 153 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 154 FRANCE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 155 FRANCE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 156 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 157 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 158 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 159 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 160 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 161 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 162 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 163 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.3 UK
10.3.3.1 Rising cancer incidence and initiatives to combat infectious diseases will support UK market
10.3.3.2 Impact of COVID-19 on the market in the UK
TABLE 164 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 165 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 166 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 167 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 168 UK: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 169 UK: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 170 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 171 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 172 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 173 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 174 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 175 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 176 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 177 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Low healthcare expenditure and slow growth in the healthcare sector have affected the market in Italy
10.3.4.2 Impact of COVID-19 on the market in Italy
TABLE 178 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 179 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 180 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 181 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 182 ITALY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 183 ITALY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 184 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 185 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 186 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 187 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 188 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 189 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 190 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 191 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Effects of the debt crisis and inadequate financing are some challenges to market growth in Spain
10.3.5.2 Impact of COVID-19 on the market in Spain
TABLE 192 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 193 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 194 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 195 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 196 SPAIN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 197 SPAIN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 198 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 199 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 200 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 201 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 202 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 203 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 204 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 205 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 206 ROE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
TABLE 207 ROE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 208 ROE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 209 ROE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 210 ROE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 211 ROE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 212 ROE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017-2019 (USD MILLION)
TABLE 213 ROE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 214 ROE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017-2019 (USD MILLION)
TABLE 215 ROE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 216 ROE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 217 ROE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 218 ROE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 219 ROE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4 APAC
TABLE 220 APAC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 221 APAC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 222 APAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 223 APAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 224 APAC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 225 APAC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 226 APAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 227 APAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 228 APAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2019 (USD MILLION)
TABLE 229 APAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 230 APAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 231 APAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 232 APAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 233 APAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 234 APAC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 235 APAC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China dominates the market in the APAC
10.4.1.2 Impact of COVID-19 on the market in China
TABLE 236 CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 237 CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 238 CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 239 CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 240 CHINA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 241 CHINA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 242 CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2019 (USD MILLION)
TABLE 243 CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 244 CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 245 CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 246 CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 247 CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 248 CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 249 CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Japan is the second-largest healthcare market in the world
10.4.2.2 Impact of COVID-19 on the market in Japan
TABLE 250 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 251 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 252 JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 253 JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 254 JAPAN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 255 JAPAN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 256 JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2019 (USD MILLION)
TABLE 257 JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 258 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 259 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 260 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 261 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 262 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 263 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 High blood donation and collection volumes indicate strong growth potential
10.4.3.2 Impact of COVID-19 on the market in India
TABLE 264 INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 265 INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 266 INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 267 INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 268 INDIA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 269 INDIA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 270 INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2019 (USD MILLION)
TABLE 271 INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 272 INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 273 INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 274 INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 275 INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 276 INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 277 INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 278 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 279 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 280 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 281 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 282 ROAPAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2019 (USD MILLION)
TABLE 283 ROAPAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 284 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2019 (USD MILLION)
TABLE 285 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2020–2025 (USD MILLION)
TABLE 286 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 287 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 288 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 289 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 290 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 291 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 REDUCTIONS IN BLOOD DONATION RATE WILL AFFECT PACE OF MARKET GROWTH IN LATAM
TABLE 292 LATAM: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 293 LATAM: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 294 LATAM: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 295 LATAM: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 296 LATAM: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 297 LATAM: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 298 LATAM: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 299 LATAM: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INFRASTRUCTURAL DEVELOPMENT AND INVESTMENTS INDICATE FUTURE GROWTH TRENDS IN THE MEA
TABLE 300 MEA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
TABLE 301 MEA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 302 MEA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2019 (USD MILLION)
TABLE 303 MEA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2020–2025 (USD MILLION)
TABLE 304 MEA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
TABLE 305 MEA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 306 MEA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 307 MEA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 196)
11.1 OVERVIEW
FIGURE 17 PRODUCT LAUNCHES—THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2017 TO JUNE 2020
11.2 MARKET SHARE ANALYSIS
FIGURE 18 BLOOD COLLECTION DEVICES MARKET SHARE ANALYSIS, BY PLAYER, 2019
11.3 BLOOD BAGS MARKET SHARE ANALYSIS
FIGURE 19 BLOOD BAGS MARKET SHARE ANALYSIS, BY PLAYER, 2019
11.4 COMPETITIVE SITUATION AND TRENDS
11.4.1 KEY PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 308 PRODUCT LAUNCHES AND ENHANCEMENTS
11.4.2 KEY PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
TABLE 309 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
11.4.3 KEY ACQUISITIONS
TABLE 310 ACQUISITIONS
11.4.4 KEY EXPANSIONS
TABLE 311 EXPANSION
12 COMPANY PROFILES (Page No. - 201)
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
12.1 BECTON, DICKINSON AND COMPANY
FIGURE 20 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
12.2 TERUMO BCT
FIGURE 21 TERUMO BCT: COMPANY SNAPSHOT
12.3 FRESENIUS KABI
FIGURE 22 FRESENIUS KABI: COMPANY SNAPSHOT
12.4 GRIFOLS
FIGURE 23 GRIFOLS: COMPANY SNAPSHOT
12.5 NIPRO MEDICAL CORPORATION
FIGURE 24 NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT
12.6 GREINER HOLDING
FIGURE 25 GREINER HOLDING: COMPANY SNAPSHOT
12.7 QUEST DIAGNOSTICS
FIGURE 26 QUEST DIAGNOSTICS: COMPANY SNAPSHOT
12.8 SARSTEDT AG & CO.
12.9 MACOPHARMA
12.10 HAEMONETICS
FIGURE 27 HAEMONETICS: COMPANY SNAPSHOT
12.11 SMITHS MEDICAL
FIGURE 28 SMITHS GROUP: COMPANY SNAPSHOT (2019)
12.12 KAWASUMI LABORATORIES
FIGURE 29 KAWASUMI LABORATORIES: COMPANY SNAPSHOT
12.13 RETRACTABLE TECHNOLOGIES
FIGURE 30 RETRACTABLE TECHNOLOGIES: COMPANY SNAPSHOT
12.14 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT
12.15 F.L. MEDICAL S.R.L
12.16 AB MEDICAL
12.17 APTACA SPA
12.18 MICSAFE MEDICAL GROUP
12.19 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.ª
12.20 AJOSHA BIO TEKNIK
12.21 PREQ SYSTEMS
12.22 CML BIOTECH
12.23 LMB TECHNOLOGIE GMBH
12.24 MITRA INDUSTRIES PRIVATE LIMITED
12.25 NEOMEDIC LIMITED
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
13 ADJACENT/RELATED MARKETS (Page No. - 244)
13.1 INTRODUCTION
13.2 APHERESIS MARKET
13.2.1 MARKET DEFINITION
13.2.2 LIMITATIONS
13.2.3 MARKET OVERVIEW
13.3 APHERESIS MARKET, BY PRODUCT
13.3.1 INTRODUCTION
TABLE 312 APHERESIS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
13.3.2 APHERESIS DISPOSABLES
TABLE 313 APHERESIS DISPOSABLES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.3.3 APHERESIS DEVICES
TABLE 314 APHERESIS DEVICES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.4 APHERESIS MARKET, BY PROCEDURE
13.4.1 INTRODUCTION
TABLE 315 APHERESIS MARKET, BY PROCEDURE, 2017–2025 (USD MILLION)
13.4.2 AUTOMATED BLOOD COLLECTION
TABLE 316 AUTOMATED BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.4.3 THERAPEUTIC APHERESIS
TABLE 317 THERAPEUTIC APHERESIS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.5 APHERESIS MARKET, BY TECHNOLOGY
13.5.1 INTRODUCTION
TABLE 318 APHERESIS MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION)
13.5.2 CENTRIFUGATION
TABLE 319 APHERESIS MARKET FOR CENTRIFUGATION, BY COUNTRY, 2017–2025 (USD MILLION)
13.5.3 MEMBRANE SEPARATION
TABLE 320 APHERESIS MARKET FOR MEMBRANE SEPARATION, BY COUNTRY, 2017–2025 (USD MILLION)
13.6 APHERESIS MARKET, BY APPLICATION
13.6.1 INTRODUCTION
TABLE 321 APHERESIS MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
13.6.2 PLASMAPHERESIS
TABLE 322 PLASMAPHERESIS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.6.3 PLATELETPHERESIS
TABLE 323 PLATELETPHERESIS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.6.4 ERYTHROCYTAPHERESIS
TABLE 324 ERYTHROCYTAPHERESIS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.6.5 LEUKAPHERESIS
TABLE 325 LEUKAPHERESIS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.6.6 PHOTOPHERESIS
TABLE 326 PHOTOPHERESIS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13.6.7 OTHER APPLICATIONS
TABLE 327 APHERESIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
13.7 APHERESIS MARKET, BY END USER
13.7.1 INTRODUCTION
TABLE 328 APHERESIS MARKET, BY END USER, 2017–2025 (USD MILLION)
13.7.2 BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS
TABLE 329 APHERESIS MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2017–2025 (USD MILLION)
13.7.3 HOSPITALS & TRANSFUSION CENTERS
TABLE 330 APHERESIS MARKET FOR HOSPITALS AND TRANSFUSION CENTERS, BY COUNTRY, 2017–2025 (USD MILLION)
13.7.4 OTHER END USERS
TABLE 331 APHERESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2025 (USD MILLION)
14 APPENDIX (Page No. - 260)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the blood collection devices market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study include publications from government sources, such as WHO, OECD, FDA, CDC, and World Bank. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global blood collection devices market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global blood collection devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the hospitals, ASCs, Nursing homes, Blood Banks and pathology laboratories) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the blood collection devices market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the global blood collection devices market and other adjucent submarkets. The research methodology and the market numbers were then validated from primaries.
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the blood collection devices market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the blood collection devices market
Report Objectives
- To define, describe, segment, and forecast the blood collection devices market based on product, application, end user, method and region
- To provide detailed information about the factors influencing market growth, such as drivers, opportunities, restraints and challenges
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall in blood collection devices market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific (APAC), Middle East and Africa
- To profile the key players in the global blood collection devices market and comprehensively analyze their core competencies3 and market shares
- To track and analyze competitive developments, such as product launches, expansions, and partnerships in the blood collection devices market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further for LATAM and MEA countriesmarket into countries.
- Product Analysis by product Matrix, which gives a detailed comparison of the product portfolios of top companiesCOMPANY INFORMATION
Get in-depth analysis of the COVID-19 impact on the Blood Collection Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Blood Collection Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Blood Collection Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Blood Collection Market